Transplacental Passage of Insulin in Pregnant Women with Insulin-Dependent Diabetes Mellitus
- 2 August 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (5) , 309-315
- https://doi.org/10.1056/nejm199008023230505
Abstract
Fetal macrosomia occurs despite nearly normal maternal blood glucose levels in women with diabetes treated with insulin. We examined the hypothesis that it may be caused by insulin transferred as an insulin-antibody complex from the mother to her fetus. We adapted and validated a method based on high-performance liquid chromatography and used it to quantitate insulin in small volumes (0.5 to 1.0 ml) of cord serum from 51 infants born to mothers with insulin-dependent diabetes mellitus. In mothers receiving only human insulin (n = 6), only human insulin was detected in cord serum. Of the remaining 45 infants, whose mothers received animal insulin during pregnancy, 28 (group 1) had levels of animal (bovine or porcine) insulin (mean [±SE], 707±163 pmol per liter) that constituted 27.4±2.5 percent of the total insulin concentration (2393±500 pmol per liter) measured in the cord serum. The cord-serum insulin concentration in the remaining 17 infants (group 2), in whom only human insulin was detected (381±56 pmol per liter), was only 15 percent of that in group 1 (P<0.001). There was a significant correlation between the maternal and the cord-serum concentrations of anti-insulin antibody and the concentration of animal insulin in the baby (r = 0.77, P<0.01, and r = 0.76, P<0.001, respectively), suggesting that the animal insulin was transferred as an insulin-antibody complex. In group 1 the mean concentration of animal insulin in cord serum was higher in the 12 infants with macrosomia than in the 16 infants without the condition (1113±321 vs. 402±110 pmol per liter; P<0.05), and the concentration of animal insulin in cord serum correlated with birth weight (r = 0.39, P<0.05). The maternal glycosylated hemoglobin values and the incidence of respiratory distress syndrome were similar in groups 1 and 2. Considerable amounts of antibody-bound insulin are transferred from mother to fetus during pregnancy in some women with insulin-dependent diabetes mellitus; the extent of transfer correlates with the maternal concentration of anti-insulin antibody. The correlation between macrosomia and the concentrations of animal insulin in cord serum indicates that the transferred insulin has biologic activity and suggests that the formation of antibody to insulin in the mother is a determinant of fetal outcome independent of maternal blood glucose levels. (N Engl J Med 1990; 323:309–15.)This publication has 22 references indexed in Scilit:
- Macrosomia in Pregnancy Complicated by Insulin-Dependent Diabetes MellitusDiabetes Care, 1987
- Relation of enteroinsular hormones at birth to macrosomia and neonatal hypoglycemia in infants of diabetic mothersThe Journal of Pediatrics, 1983
- Banting Lecture 1980. Of pregnancy and progenyDiabetes, 1980
- FETAL ORIGIN OF AMNIOTIC FLUID INSULIN IN THE HUMAN MOTHERClinical Endocrinology, 1980
- The Infant of the Diabetic MotherNew England Journal of Medicine, 1979
- Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeksPublished by Elsevier ,1969
- THE ROLE OF THE HUMAN PLACENTA IN THE TRANSFER AND METABOLISM OF INSULIN*Journal of Clinical Investigation, 1962
- INSULIN-I131 METABOLISM IN HUMAN SUBJECTS: DEMONSTRATION OF INSULIN BINDING GLOBULIN IN THE CIRCULATION OF INSULIN TREATED SUBJECTS 1Journal of Clinical Investigation, 1956
- WEIGHT AND LENGTH AT BIRTH OF INFANTS OF DIABETIC MOTHERSActa Endocrinologica, 1954
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949